Abdominal aortic aneurysm (AAA) is a permanent and irreversible localized dilatation of the abdominal aorta with a mortality after rupture ranging from 60% to 70%. Endovascular abdominal aortic aneurysm repair (EVAR) has been considered as the first-line option for the treatment of AAA owing to its clinical safety and effectiveness. However, the occurrence of complications in long-term follow-up such as stent displacement and endoleak is still raising concern. To date, "ENGAGE" is the largest long-term registration study of endovascular treatment of AAA. Here, the authors, based on the 8-year follow-up results of the "ENGAGE" study and relevant literature analysis, systematically introduce the current situation and outlook of endovascular treatment of AAA.